Alpha 2.0
Login Register
» Authors » A Janu

A Janu

Explore the profile of A Janu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 8
Followers 0
Related Specialties
Oncology
Gastroenterology
Top 10 Co-Authors
V Noronha
K Prabhash
V M Patil
A Mahajan
A Joshi
S Zanwar
N Menon
S Goud
R Kumar
A K Singh
Published In
Clin Oncol (R Coll Radiol)
Indian J Cancer
Esophagus
Affiliations
Soon will be listed here.
Recent Articles
1.
The Role of Systemic Therapy in Patients with Advanced Non-small Cell Lung Cancer and a Poor Eastern Cooperative Oncology Group Performance Status
Shah M, Noronha V, Menon N, Singh A, Shah A, Kumar P, et al.
Clin Oncol (R Coll Radiol) . 2023 Dec; 36(2):128-129. PMID: 38097463
No abstract available.
2.
Infections in Patients with Advanced-stage Epidermal Growth Factor Receptor-mutant Lung Cancer - a Post-hoc Analysis of a Randomised Trial
Sahu H, Patil V, Menon N, Singh A, Biswas S, Janu A, et al.
Clin Oncol (R Coll Radiol) . 2023 Oct; 35(12):811-812. PMID: 37838606
No abstract available.
3.
Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial
Noronha V, Patil V, Menon N, Joshi A, Goud S, More S, et al.
Esophagus . 2022 May; 19(4):670-682. PMID: 35614161
Background: Improving outcomes in locally advanced esophageal/GEJ squamous cell cancer (SCC) is an unmet need. We investigated the addition of oral metronomic chemotherapy (OMC) following definitive chemoradiotherapy (CRT). Materials And...
4.
Practice Patterns and Outcomes for Pemetrexed Plus Platinum Doublet as Neoadjuvant Chemotherapy in Adenocarcinomas of Lung: Looking Beyond the Usual Paradigm
Noronha V, Zanwar S, Joshi A, Patil V, Mahajan A, Janu A, et al.
Clin Oncol (R Coll Radiol) . 2017 Dec; 30(1):23-29. PMID: 29239731
Aims: Neoadjuvant chemotherapy (NACT) is the standard of care in non-small cell lung cancers (NSCLC) with locally advanced N2 disease. There is a scarcity of data for the pemetrexed-platinum regimen...
5.
Repeat biopsy in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer: Feasibility, limitations, and clinical utility in Indian patients
Zanwar S, Noronha V, Joshi A, Patil V, Chougule A, Kumar R, et al.
Indian J Cancer . 2017 Dec; 54(1):280-284. PMID: 29199706
Introduction: The feasibility and success rate of repeat biopsy for epidermal growth factor receptor (EGFR) mutation-positive lung cancers that have progressed on tyrosine kinase inhibitors (TKIs) are varied and merits...